Signal Detection and Risk Management

Learn the principles of signal detection, signal management and risk management

Date icon
No available dates
Attendance icon

On location

Language icon

English

Price icon
30,000 DKK ex VAT

(app. 4,033 EUR ex VAT)

Summary

This accredited course (ECTS 5), offered in collaboration with University of Copenhagen, covers principles of signal detection, signal management and risk management. We begin at the initial detection of potential signals in different data sources and continue through the signal management process to signal validation and assessment of the benefit-risk balance.

The five day course also deals with risk management, risk minimisation activities and risk communication. We cover the aspects of regulations, roles and responsibilities of the marketing authorisation holder, regulatory authorities, ethics committees, HCPs, and patients.


Teaching methods
  • Online part: e-lessons that introduce you to the concepts of signal detection, signal management, and risk management.
  • On location part: lectures and group work on real and simulated safety scenarios.

    Keywords

    • Data sources
    • Methods for signal detection
    • Signal management
    • Risk management

    Save information for later
    Read more

    Course leader & lecturers

    • Morten Andersen
      Course leader
      Professor in Pharmacovigilance
      University of Copenhagen
    • Wasim Anwar
      Course leader
      Vice President & Deputy QPPV, Global Safety
      Novo Nordisk A/S
    • Claudia Pierleoni-Nielsen
      Lecturer
      Director, Head of Safety Surveillance, Global Safety
      LEO Pharma A/S
    • Atheline Major-Pedersen
      Lecturer
      Safety Surveillance Principal Specialist, Global Safety
      Novo Nordisk A/S
    • Alicia Toft-Hansen
      Lecturer
      Safety Surveillance Specialist
      Novo Nordisk A/S
    • Per Bengtson
      Lecturer
      Senior Safety Medical Writer
      Ferring Pharmaceuticals A/S
    • Charlotta Thörn Jørgensen
      Lecturer
      Senior Safety Physician
      Ferring Pharmaceuticals A/S
    • Nicklas Hasselblad Lundstrøm
      Lecturer
      Pharmacovigilance officer
      Lægemiddelstyrelsen
    • Maurizio Sessa
      Lecturer
      Assistant Professor of Pharmacoepidemiology
      Københavns Universitet
    • Marcus Schartau
      Lecturer
      Safety Surveillance Risk Management Specialist
      Novo Nordisk A/S
    • Fredrik Brounéus
      Lecturer
      Pharmacist, Communications Officer
      Uppsala Monitoring Centre
    • Cathrina Karup
      Lecturer

      Ferring Pharmaceuticals A/S
    See all

    Watch the video

    Is this course for you?

    This course is valuable for all experienced pharmacovigilance professionals, e.g. safety surveillance advisers, safety scientists, and patient safety associates.

    What you will learn

    1. How to explain and describe data sources and methods for signal detection.
    2. How to describe relevant information flows, legislation and guidelines on signal management and risk management.
    3. How to explain key concepts related to signal management and risk management.
    4. How to explain and describe the roles and responsibilities of regulatory agencies and marketing authorisation holders.

    What your company will get

    1. An employee who can independently integrate and evaluate safety information from various sources.
    2. An employee who can critically assess information and reflect on the appropriate actions to take.
    3. An employee who can develop a strategy for risk management.
    4. An employee who can plan risk minimisation activities and risk communication for different safety scenarios.

    Course information

    Literature

    Prior to the course you get access to mandatory and optional readings via your personal Atrium log-in. Please familiarise yourself with the mandatory readings before starting the course. The mandatory readings are also part of the examination syllabus.

    Readings include selected chapters from textbooks, including Mann’s Pharmacovigilance (current edition) as well as relevant legislation, including EU directives and regulations, good pharmacovigilance practice guidelines, scientific papers and review papers.

    Prerequisites

    Applicants must meet the following criteria:

    • A relevant BA degree or equivalent
    • A minimum of 2 years of relevant job experience

    Examination

    The exam is a written assignment and takes place digitally (the online exam platform of the University of Copenhagen).

    Date: 22 December 2022

    Course leaders

    Morten Andersen
    Professor in Pharmacovigilance
    University of Copenhagen
    Wasim Anwar
    Vice President & Deputy QPPV, Global Safety
    Novo Nordisk A/S

    Lecturers

    Morten Andersen
    Professor in Pharmacovigilance
    University of Copenhagen
    Wasim Anwar
    Vice President & Deputy QPPV, Global Safety
    Novo Nordisk A/S
    Claudia Pierleoni-Nielsen
    Director, Head of Safety Surveillance, Global Safety
    LEO Pharma A/S
    Atheline Major-Pedersen
    Safety Surveillance Principal Specialist, Global Safety
    Novo Nordisk A/S
    Alicia Toft-Hansen
    Safety Surveillance Specialist
    Novo Nordisk A/S
    Per Bengtson
    Senior Safety Medical Writer
    Ferring Pharmaceuticals A/S
    Charlotta Thörn Jørgensen
    Senior Safety Physician
    Ferring Pharmaceuticals A/S
    Nicklas Hasselblad Lundstrøm
    Pharmacovigilance officer
    Lægemiddelstyrelsen
    Maurizio Sessa
    Assistant Professor of Pharmacoepidemiology
    Københavns Universitet
    Marcus Schartau
    Safety Surveillance Risk Management Specialist
    Novo Nordisk A/S
    Fredrik Brounéus
    Pharmacist, Communications Officer
    Uppsala Monitoring Centre
    Cathrina Karup

    Ferring Pharmaceuticals A/S

    You may also be interested in these courses

    Want to know more or need help?

    Contact Educational Programme Leader Lone Rex at +45 20 62 11 46

    Send me a message